Jiangbo Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
07 Jun 2011	Form 3: Zhou George, Director No securities owned
14 Jul 2010	Form 3: Jin Linxian, Chief Executive Officer No securities owned
16 Sep 2008	Form 3: Wang John, Director Holds 0 shares of Common Stock, par value $0.001
05 Sep 2008	Form 3: Marks Michael, Director Holds 50,000 shares of Common Stock, par value $0.001
05 Feb 2008	Form 3: Verda International Ltd, 10% owner Holds 194,263,661 shares of Common Stock
05 Feb 2008	Form 3: Wang Renhui, 10% owner Holds 22,384,290 shares of Common Stock
04 Feb 2008	Form 3: Arboleda Rodrigo, Director Holds 500,000 shares of Common Stock
28 Jan 2008	Form 3: Xue Hong, Controller No securities owned
28 Jan 2008	Form 3: Xin Jingsheng, Director of Equipment No securities owned
28 Jan 2008	Form 3: Zhang Yihua, Director No securities owned
28 Jan 2008	Form 3: Yang Weidong, VP, Director of Sales No securities owned
28 Jan 2008	Form 3: Xu Haibo, Director No securities owned
28 Jan 2008	Form 3: Huang Lei, Director No securities owned
28 Jan 2008	Form 3: Ge Jian, Director Holds 399,719 shares of Common Stock
28 Jan 2008	Form 3: Feng Xiaowei, Director No securities owned
28 Jan 2008	Form 3: Sung Elsa, Chief Financial Officer Holds 20,000 shares of Common Stock
28 Jan 2008	Form 3: Cao Wubo, Director Holds 194,263,661 shares of Common Stock
28 Jan 2008	Form 3: Dong Lining, VP, Director of Technology No securities owned
10 Jul 2007	Form 3: Genesis Technology Group Inc, 10% owner · GOLD HORSE INTERNATIONAL, INC. Holds 8,542,500 shares of Common Stock, $0.0001 par value
10 Oct 2006	Form 3: Genesis Technology Group Inc, 10% owner · Lotus Pharmaceuticals, Inc. Holds 6,736,896 shares of Common Stock, $0.001 par value

Comments